Radiosynthesis and preclinical evaluation of [11 C]Cimbi-701 - Towards the imaging of cerebral 5-HT7 receptors

Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

Standard

Radiosynthesis and preclinical evaluation of [11 C]Cimbi-701 - Towards the imaging of cerebral 5-HT7 receptors. / L 'Estrade, Elina T; Shalgunov, Vladimir; Edgar, Fraser G; Strebl-Bantillo, Martin G; Xiong, Mengfei; Crestey, François; Neelamegam, Ramesh; Dyssegaard, Agnete; Lehel, Szabolcs; Erlandsson, Maria; Ohlsson, Tomas; Hooker, Jacob M; Knudsen, Gitte M; Herth, Matthias M; Hansen, Hanne D.

I: Journal of Labelled Compounds and Radiopharmaceuticals, Bind 63, 2020, s. 46-55.

Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

Harvard

L 'Estrade, ET, Shalgunov, V, Edgar, FG, Strebl-Bantillo, MG, Xiong, M, Crestey, F, Neelamegam, R, Dyssegaard, A, Lehel, S, Erlandsson, M, Ohlsson, T, Hooker, JM, Knudsen, GM, Herth, MM & Hansen, HD 2020, 'Radiosynthesis and preclinical evaluation of [11 C]Cimbi-701 - Towards the imaging of cerebral 5-HT7 receptors', Journal of Labelled Compounds and Radiopharmaceuticals, bind 63, s. 46-55. https://doi.org/10.1002/jlcr.3808

APA

L 'Estrade, E. T., Shalgunov, V., Edgar, F. G., Strebl-Bantillo, M. G., Xiong, M., Crestey, F., Neelamegam, R., Dyssegaard, A., Lehel, S., Erlandsson, M., Ohlsson, T., Hooker, J. M., Knudsen, G. M., Herth, M. M., & Hansen, H. D. (2020). Radiosynthesis and preclinical evaluation of [11 C]Cimbi-701 - Towards the imaging of cerebral 5-HT7 receptors. Journal of Labelled Compounds and Radiopharmaceuticals, 63, 46-55. https://doi.org/10.1002/jlcr.3808

Vancouver

L 'Estrade ET, Shalgunov V, Edgar FG, Strebl-Bantillo MG, Xiong M, Crestey F o.a. Radiosynthesis and preclinical evaluation of [11 C]Cimbi-701 - Towards the imaging of cerebral 5-HT7 receptors. Journal of Labelled Compounds and Radiopharmaceuticals. 2020;63:46-55. https://doi.org/10.1002/jlcr.3808

Author

L 'Estrade, Elina T ; Shalgunov, Vladimir ; Edgar, Fraser G ; Strebl-Bantillo, Martin G ; Xiong, Mengfei ; Crestey, François ; Neelamegam, Ramesh ; Dyssegaard, Agnete ; Lehel, Szabolcs ; Erlandsson, Maria ; Ohlsson, Tomas ; Hooker, Jacob M ; Knudsen, Gitte M ; Herth, Matthias M ; Hansen, Hanne D. / Radiosynthesis and preclinical evaluation of [11 C]Cimbi-701 - Towards the imaging of cerebral 5-HT7 receptors. I: Journal of Labelled Compounds and Radiopharmaceuticals. 2020 ; Bind 63. s. 46-55.

Bibtex

@article{bd97b8398c98460f9b6e14937c41e271,
title = "Radiosynthesis and preclinical evaluation of [11 C]Cimbi-701 - Towards the imaging of cerebral 5-HT7 receptors",
abstract = "PURPOSE: The serotonin 7 (5-HT7 ) receptor is suggested to be involved in a broad variety of CNS disorders, but very few in vivo tools exist to study this important target. olecular imaging with positron emission tomography (PET) would enable an in vivo characterization of the 5-HT7 receptor. However, no clinical PET radiotracer exists for this receptor and thus we aimed to develop such a tracer. In this study, we present the preclinical evaluation of [11 C]Cimbi-701.PROCEDURES: Cimbi-701 was synthesized in a one-step procedure starting from SB-269970. Its selectivity profile was determined using an academic screening platform (NIMH Psychoactive Drug Screening Program). Successful radiolabeling of [11 C]Cimbi-701 and subsequent in vivo evaluation was conducted in rats, pigs and baboon. In vivo specificity was investigated by 5-HT7 and σ receptor blocking studies. P-gp efflux transporter dependency was investigated using elacridar.RESULTS: [11 C]Cimbi-701 could successfully be synthesized. Selectivity profiling revealed high affinity for the 5-HT7 (Ki = 18 nM), σ-1 (Ki = 9.2 nM) and σ-2 (Ki = 1.6 nM) receptors. In rats, [11 C]Cimbi-701 acted as a strong P-gp substrate. After P-gp inhibition, rat brain uptake could specifically be blocked by 5-HT7 and σ receptor ligands. In pig, high brain uptake and specific 5-HT7 and σ-receptor binding was found for [11 C]Cimbi-701 without P-gp inhibition. Finally, low brain uptake was found in baboons.CONCLUSIONS: Both the specific σ-receptor binding and the low brain uptake of [11 C]Cimbi-701 displayed in baboons, discouraged further translation to humans. Instead, we suggest exploration of this structural class, as results indicate that selective 5-HT7 receptor imaging might be possible when more selective non-P-gp substrates are identified.",
author = "{L 'Estrade}, {Elina T} and Vladimir Shalgunov and Edgar, {Fraser G} and Strebl-Bantillo, {Martin G} and Mengfei Xiong and Fran{\c c}ois Crestey and Ramesh Neelamegam and Agnete Dyssegaard and Szabolcs Lehel and Maria Erlandsson and Tomas Ohlsson and Hooker, {Jacob M} and Knudsen, {Gitte M} and Herth, {Matthias M} and Hansen, {Hanne D}",
note = "This article is protected by copyright. All rights reserved.",
year = "2020",
doi = "10.1002/jlcr.3808",
language = "English",
volume = "63",
pages = "46--55",
journal = "Journal of Labelled Compounds and Radiopharmaceuticals",
issn = "0362-4803",
publisher = "JohnWiley & Sons Ltd",

}

RIS

TY - JOUR

T1 - Radiosynthesis and preclinical evaluation of [11 C]Cimbi-701 - Towards the imaging of cerebral 5-HT7 receptors

AU - L 'Estrade, Elina T

AU - Shalgunov, Vladimir

AU - Edgar, Fraser G

AU - Strebl-Bantillo, Martin G

AU - Xiong, Mengfei

AU - Crestey, François

AU - Neelamegam, Ramesh

AU - Dyssegaard, Agnete

AU - Lehel, Szabolcs

AU - Erlandsson, Maria

AU - Ohlsson, Tomas

AU - Hooker, Jacob M

AU - Knudsen, Gitte M

AU - Herth, Matthias M

AU - Hansen, Hanne D

N1 - This article is protected by copyright. All rights reserved.

PY - 2020

Y1 - 2020

N2 - PURPOSE: The serotonin 7 (5-HT7 ) receptor is suggested to be involved in a broad variety of CNS disorders, but very few in vivo tools exist to study this important target. olecular imaging with positron emission tomography (PET) would enable an in vivo characterization of the 5-HT7 receptor. However, no clinical PET radiotracer exists for this receptor and thus we aimed to develop such a tracer. In this study, we present the preclinical evaluation of [11 C]Cimbi-701.PROCEDURES: Cimbi-701 was synthesized in a one-step procedure starting from SB-269970. Its selectivity profile was determined using an academic screening platform (NIMH Psychoactive Drug Screening Program). Successful radiolabeling of [11 C]Cimbi-701 and subsequent in vivo evaluation was conducted in rats, pigs and baboon. In vivo specificity was investigated by 5-HT7 and σ receptor blocking studies. P-gp efflux transporter dependency was investigated using elacridar.RESULTS: [11 C]Cimbi-701 could successfully be synthesized. Selectivity profiling revealed high affinity for the 5-HT7 (Ki = 18 nM), σ-1 (Ki = 9.2 nM) and σ-2 (Ki = 1.6 nM) receptors. In rats, [11 C]Cimbi-701 acted as a strong P-gp substrate. After P-gp inhibition, rat brain uptake could specifically be blocked by 5-HT7 and σ receptor ligands. In pig, high brain uptake and specific 5-HT7 and σ-receptor binding was found for [11 C]Cimbi-701 without P-gp inhibition. Finally, low brain uptake was found in baboons.CONCLUSIONS: Both the specific σ-receptor binding and the low brain uptake of [11 C]Cimbi-701 displayed in baboons, discouraged further translation to humans. Instead, we suggest exploration of this structural class, as results indicate that selective 5-HT7 receptor imaging might be possible when more selective non-P-gp substrates are identified.

AB - PURPOSE: The serotonin 7 (5-HT7 ) receptor is suggested to be involved in a broad variety of CNS disorders, but very few in vivo tools exist to study this important target. olecular imaging with positron emission tomography (PET) would enable an in vivo characterization of the 5-HT7 receptor. However, no clinical PET radiotracer exists for this receptor and thus we aimed to develop such a tracer. In this study, we present the preclinical evaluation of [11 C]Cimbi-701.PROCEDURES: Cimbi-701 was synthesized in a one-step procedure starting from SB-269970. Its selectivity profile was determined using an academic screening platform (NIMH Psychoactive Drug Screening Program). Successful radiolabeling of [11 C]Cimbi-701 and subsequent in vivo evaluation was conducted in rats, pigs and baboon. In vivo specificity was investigated by 5-HT7 and σ receptor blocking studies. P-gp efflux transporter dependency was investigated using elacridar.RESULTS: [11 C]Cimbi-701 could successfully be synthesized. Selectivity profiling revealed high affinity for the 5-HT7 (Ki = 18 nM), σ-1 (Ki = 9.2 nM) and σ-2 (Ki = 1.6 nM) receptors. In rats, [11 C]Cimbi-701 acted as a strong P-gp substrate. After P-gp inhibition, rat brain uptake could specifically be blocked by 5-HT7 and σ receptor ligands. In pig, high brain uptake and specific 5-HT7 and σ-receptor binding was found for [11 C]Cimbi-701 without P-gp inhibition. Finally, low brain uptake was found in baboons.CONCLUSIONS: Both the specific σ-receptor binding and the low brain uptake of [11 C]Cimbi-701 displayed in baboons, discouraged further translation to humans. Instead, we suggest exploration of this structural class, as results indicate that selective 5-HT7 receptor imaging might be possible when more selective non-P-gp substrates are identified.

U2 - 10.1002/jlcr.3808

DO - 10.1002/jlcr.3808

M3 - Journal article

C2 - 31674045

VL - 63

SP - 46

EP - 55

JO - Journal of Labelled Compounds and Radiopharmaceuticals

JF - Journal of Labelled Compounds and Radiopharmaceuticals

SN - 0362-4803

ER -

ID: 231253390